- Home
- FDMT vs NATH Comparison
FDMT vs NATH Comparison
Compare FDMT & NATH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FDMT | NATH |
|---|---|---|
| Founded | 2013 | 1916 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 476.9M | 414.4M |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | FDMT | NATH |
|---|---|---|
| Price | $9.48 | $100.76 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 8 | 0 |
| Target Price | ★ $34.13 | N/A |
| AVG Volume (30 Days) | ★ 728.1K | 95.1K |
| Earning Date | 02-27-2026 | 02-05-2026 |
| Dividend Yield | N/A | ★ 1.99% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 5.20 |
| Revenue | $120,000.00 | ★ $157,784,000.00 |
| Revenue This Year | $21,227.03 | N/A |
| Revenue Next Year | $161.87 | N/A |
| P/E Ratio | ★ N/A | $19.37 |
| Revenue Growth | ★ 605.88 | 7.79 |
| 52 Week Low | $2.24 | $88.00 |
| 52 Week High | $12.34 | $118.50 |
Technical Indicators
Market Signals| Indicator | FDMT | NATH |
|---|---|---|
| Relative Strength Index (RSI) | 59.94 | 63.53 |
| Support Level | $8.75 | $100.25 |
| Resistance Level | $9.78 | $101.32 |
| Average True Range (ATR) | 0.63 | 0.70 |
| MACD | 0.10 | -0.20 |
| Stochastic Oscillator | 83.00 | 49.61 |
Price Performance
Historical ComparisonAbout FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.
About NATH Nathan's Famous Inc.
Nathan's Famous Inc is an owner of fast food franchises in the United States. The company's reportable segment includes the Branded Product Program, Product licensing, Restaurant operations and Corporate. Branded Product Program derives revenue principally from the sale of hot dog products either directly to foodservice operators or to various foodservice distributors who resell the products to foodservice operators. It generates maximum revenue from the Branded Product Program segment. Geographically, it derives a majority of revenue from the United States.